Atrial septal defect percutaneous closure benefits: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Adding CME Category::Cardiology) |
|||
| (17 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
{{Atrial septal defect}} | {{Atrial septal defect}} | ||
{{CMG}}; '''Associate | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com]; {{CZ}} '''Assistant Editor(s)-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@elon.edu] | ||
==Overview== | ==Overview== | ||
==Benefits of percutaneous closure== | |||
The percutaneous closure of [[Atrial septal defect ostium secundum|ostium secundum]] is the method of choice in many centers.<ref>{{cite journal | author = Bjørnstad P | title = Is interventional closure the current treatment of choice for selected patients with deficient atrial septation? | journal = Cardiol Young | volume = 16 | issue = 1 | pages = 3-10 | year = 2006 | id = PMID 16454871}}</ref><ref name="pmid10525508">{{cite journal| author=Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A| title=Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. | journal=Heart | year= 1999 | volume= 82 | issue= 5 | pages= 559-62 | pmid=10525508 | doi= | pmc=PMC1760778 | url= }} </ref>. The benefits that can be associated with the closure are as follow: | |||
====Disease Related Benefits==== | |||
*Fewer complications compared to [[Atrial septal defect surgical closure | surgical closure]]. | |||
*Reduced need for [[blood transfusion]]s. | |||
*Symptomatic improvement. | |||
*Regression of [[positive airway pressure]]. | |||
*Positive changes in right ventricle performance. | |||
*Improved functional capacity.<ref name="pmid15708694">{{cite journal| author=Salehian O, Horlick E, Schwerzmann M, Haberer K, McLaughlin P, Siu SC et al.| title=Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. | journal=J Am Coll Cardiol | year= 2005 | volume= 45 | issue= 4 | pages= 499-504 | pmid=15708694 | doi=10.1016/j.jacc.2004.10.052 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15708694 }} </ref> | |||
**Improved left atrial volume index. | |||
**Improved left ventricular myocardial performance index. | |||
**Improved right ventricular myocardial performance index. | |||
**Improved peak oxygen uptake. | |||
====Other Benefits==== | |||
* Less invasive no need for [[cardiopulmonary bypass]]. | |||
* | |||
* Successful implantation rates of more than 96%. | * Successful implantation rates of more than 96%. | ||
* Established practice(done in most hospital these days) | * Established practice (done in most hospital these days). | ||
* Cost-effective. | |||
* Shorter hospital stays. | |||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
==See also== | |||
*[[Atrioventricular septal defect]] | |||
*[[Congenital heart disease]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Embryology]] | |||
[[Category:Disease]] | |||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Overview complete]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 02:22, 15 March 2016
|
Atrial Septal Defect Microchapters | |
|
Treatment | |
|---|---|
|
Surgery | |
|
| |
|
Special Scenarios | |
|
Case Studies | |
|
Atrial septal defect percutaneous closure benefits On the Web | |
|
American Roentgen Ray Society Images of Atrial septal defect percutaneous closure benefits | |
|
Atrial septal defect percutaneous closure benefits in the news | |
|
Risk calculators and risk factors for Atrial septal defect percutaneous closure benefits | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3] Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]
Overview
Benefits of percutaneous closure
The percutaneous closure of ostium secundum is the method of choice in many centers.[1][2]. The benefits that can be associated with the closure are as follow:
Disease Related Benefits
- Fewer complications compared to surgical closure.
- Reduced need for blood transfusions.
- Symptomatic improvement.
- Regression of positive airway pressure.
- Positive changes in right ventricle performance.
- Improved functional capacity.[3]
- Improved left atrial volume index.
- Improved left ventricular myocardial performance index.
- Improved right ventricular myocardial performance index.
- Improved peak oxygen uptake.
Other Benefits
- Less invasive no need for cardiopulmonary bypass.
- Successful implantation rates of more than 96%.
- Established practice (done in most hospital these days).
- Cost-effective.
- Shorter hospital stays.
References
- ↑ Bjørnstad P (2006). "Is interventional closure the current treatment of choice for selected patients with deficient atrial septation?". Cardiol Young. 16 (1): 3–10. PMID 16454871.
- ↑ Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A (1999). "Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder". Heart. 82 (5): 559–62. PMC 1760778. PMID 10525508.
- ↑ Salehian O, Horlick E, Schwerzmann M, Haberer K, McLaughlin P, Siu SC; et al. (2005). "Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects". J Am Coll Cardiol. 45 (4): 499–504. doi:10.1016/j.jacc.2004.10.052. PMID 15708694.